CAS: 571189-23-6; Tert-Butyl 4-(2-Aminopyridin-4-yl)Piperazine-1-Carboxylate

该化合物是一种受保护的管子衍生物,其成分为Boc(乙氧碳基)组和2-氨基-4-丙烯基替代体,该化合物是有机合成的多种中间体,特别是在制药研究中,用于开发生物活性分子和药物候选物.该物质组在温酸条件下增强稳定性,促进选择性地减少保护,使控制功能化.2-minino-4-pyridinyl moneity有助于其在金属协调和环化学中的用途.其定义明确的结构和高纯度使其适合于在药用化学和离子设计中的精确应用.建议在惰性条件下妥善处理和储存,以保持其完整性.

结构式图片

相似化合物

959986-12-0 633283-63-3 470442-95-6

欧盟法规

C&L通报

上下游产品

2-Amino-4-chloropyridine 1-t-Butoxycarbonylpiperazine 4-fluoro-2-nitropyridine

合成工艺路线路线简述

  • 合成目标产物 1-Boc-4-(2-Amino-4-Pyridinyl)-Piperazine 主要起始原料 2-Amino-4-Chloropyridine And 1-Boc-Piperazine
  • (文献来源)合成步骤主要原料 2-Amino-4-Chloropyridine 和 1-Boc-Piperazine
📜Tert-Butyl 4-(2-Nitropyridin-4-yl)Piperazine-1-Carboxylate置于palladium On Activated Charcoal,氢气,溶剂黄146体系中,用 甲醇 作为反应溶剂,化学反应 4.0H,反应生成 1-Boc-4-(2-氨基-4-吡啶基)哌嗪
参考文献:Antimalarial Lead-Optimization Studies On A 2,6-Imidazopyridine Series Within A Constrained Chemical Space To Circumvent Atypical Dose-response Curves Against Multidrug Resistant Parasite Strains
标题:Antimalarial Lead-Optimization Studies On A 2,6-Imidazopyridine Series Within A Constrained Chemical Space To Circumvent Atypical Dose-response Curves Against Multidrug Resistant Parasite Strains
摘要:A Lead-Optimization Program Around A 2,6-Imidazopyridine Scaffold Was Initiated Based On The Two Early Lead Compounds,1 And 2,That Were Shown To Be Efficacious In An In Vivo Humanized Plasmodium Falciparum Nodscidil2R Gamma Null Mouse Malaria Infection Model. The Observation Of Atypical Dose-Response Curves When Some Compounds Were Tested Against Multidrug Resistant Malaria Parasite Strains Guided The Optimization Process To Define A Chemical Space That Led To Typical Sigmoidal Dose-Response And Complete Kill Of Multidrug Resistant Parasites. After A Structure And Property Analysis Identified Such A Chemical Space,Compounds Were Prepared That Displayed Suitable Activity,Adme,And Safety Profiles With Respect To Cytotoxicity And Herg Inhibition.
DOI:10.1021/acs.Jmedchem.8B01333

海关参考信息

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献

参考DOI号:10.1016/j.bmc.2007.12.024
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知